MYD88 L265P Mutation Molecular Detection

Synonyms	LAB14271 MYD88 L265P MUTATION ANALYSIS
Cerner Name	HLX MYD88 L265P Case
Clinical Info	MYD88 L265P mutation is present in approximately 90% of cases of Waldenstrom macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) cases. Detection of MYD88 L265P mutation is useful in differentiating LPL from other B-cell lymphoproliferative disorders with overlapping clinicopathological features.
Specimen Sources	Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous Bone Marrow
Specimen Types	Aspirate Blood Bone Marrow
Specimen Volume	1-3 mL Whole Blood or Bone Marrow
Container	Lavender Top Tube
Collection Instructions	Container/Tube: Lavender Top Tube Specimen: 1-3 mL Whole Blood or Bone Marrow
Transport Instructions	Room Temperature
Specimen Stability	Specimens are stable for a week refrigerated
Methodology	Allele specific Real Time PCR
Days Performed	Monday through Friday. TAT: 8 calendar Days
Performing Laboratories	Northwell Health Laboratories
CPT	81305
PDM	248467
Results
Result Interpretation Detected (mutation is present) Not detected (mutation is absent)
Forms	Heme/Onc Requisition Molecular test Requisition Form

Molpath Inhouse LAB14271

Synonyms